Brain type natriuretic peptide (BNP) - A marker of new millennium in diagnosis of congestive heart failure

Indian Journal of Clinical Biochemistry

Volumn 22, Issue 1, 2007, Pages 4-9

  Raizada, Arun ^a   Bhandari, Suman ^a   Khan, Muzaiyan Ahmed ^b   Singh, Harsh Vardhan ^c   Thomas, Sherin ^a   Sarabhai, Vikram ^a   Singh, Neelima ^d   Trehan, Naresh ^a  

^a ESCORTS HEART INSTITUTE AND RESEARCH CENTRE   (India)

^b PEOPLE S COLLEGE OF DENTAL SCIENCES AND RESEARCH CENTRE   (India)

^c HINDU RAO HOSPITAL   (India)

^d G R MEDICAL COLLEGE   (India)

Author keywords

Amino terminal pro brain natriuretic peptide; B type natriuretic peptide; Congestive heart failure; Left ventricular ejection fraction; Myocardial infarction

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CANDESARTAN; DIURETIC AGENT; NESIRITIDE; SPIRONOLACTONE; VALSARTAN; VASODILATOR AGENT;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM EXAMINATION; CONGESTIVE HEART FAILURE; DEVELOPING COUNTRY; DISEASE COURSE; DISEASE MARKER; DRUG EFFECT; DRUG MECHANISM; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPOTENSION; MORTALITY; PATIENT ASSESSMENT; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION; RECOMMENDED DRUG DOSE; SENSITIVITY AND SPECIFICITY; SURVIVAL;

EID: 33947177041     PISSN: 09701915     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02912873     Document Type: Article

References (39)

1. Dorothea KT, Apostolos IK, Kostas GR, Aspostolos Z. Brain natriuretic peptide. Hell J card 2003;44:266-70.
2. Sudoh T, Kangawa K, Miniamo N. A new natriuretic peptide in porcine brain. Nature 1988;332:78-81.
3. Kambayashi Y, Nakaoka K. Isolation and sequence determination of human BNP. Febs letters 1990;259:341-5.
4. Pfister R, Schneider CA. Natriuretic peptides BNP and NT-pro-BNP: established laboratory markers in clinical practice or just perspectives? Clin Chim Acta 2004 Nov;349(1-2):25-38.
5. Thurpraf DJ, Glembotski CC. Differential effects of protein kinase C, Ras and Raf-1 kinase on induction of the cardiac B-type natriuretic peptide gene through a critical promotor-proximal M-CAT element. J Biol Chem 1997; 272:7464-72.
6. Ogowa E. Fibronectin signaling stimulates BNP gene transcription by inhibiting neuron-restrictive silencer element dependent system repression. Cardiovascular Res. Commun. Cardiovascular Res 2001;53:451-9.
7. Hautala N. Pressure overload increase GATA 4 binding activity via endothelin I. Circulation 2001;103:730-5.
8. Tsutamoto T. Attenuation of compensation of endogenous cardiac natriuretic peptides system in chronic heart failure. Circulation 1997 ;96:509-16.
9. Wei CM. Natriuretic peptide system in human heart failure. Circulation 1993;88:1004-9.
10. Christopher B, Granger. Effects of candersaritan in patients with chronic heart failure and reduced left ventricular systolic function intolerant to angiotensin converting enzyme (ACE) inhibitors. The CHARMS - Alternative trial. Lancet 2003 Sep;326:772-6.
11. Yoshimura M. B-tNP as a marker of effects of enalapril in patients with heart failure. Am J Med 2002;112:716-30.
12. Yamamoto K. Superiority of BNP as a hormonal markers of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996;28:988-94.
13. Troughton RW. Treatment of heart failure guided by plasma amino terminal brain natriuretic peptides (Nt-BNP) concentrations. Lancet 2000;355:1126-30.
14. Yasue H, Yoshimura M. Localization and mechanism of secretion of B-type natriuretic peptides in comparison with those of A type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994;90:195-203.
15. Omnland T, Aakvaag A. Plasma brain natriuretic peptides as an indicator of Left ventricular systolic function and long term survival after acute myocardial infarction. Comparison with plasma ANP and N terminal pro atrial natriuretic peptides. Circulation 1996;93 :1963-9.
16. Kuchner N, Printzen G, et al. Low pro-brain natriuretic peptide benign clinical outcome in acute pulmonary embolism. Circulation 2003 April 1;107(12):1576-8.
17. Thurpraf D J & Glembotski CC. Differential effects of protein kinase C, Ras and Raf-1 kinase on induction of the cardiac B-type natriuretic peptide gene through a critical promotor-proximal M-CAT element. J Biol Chem 1997;272:7464-72.
18. WuAH Smith A, Wieczorrek S, Mather JF, Duncan B, White CM, McGill Katten D. Biological variations for NT-pro & BNP and implications for therapeutic monitoring of patients with congestive heart failure. Hel Am J Car 2003 Sep1;92:5;628-31.
19. Henricksen JH, Gotze JP, Fuglsang S, Christensen E, Bendtsen F, Mollers. Increased circulating proBNP and BNP in patients with cirrhosis related to cardiovascular dysfunction and severity of disease. Gut 2003 Oct;52:10 :1511-7.
20. Gottelib SS. Prognostic importance of aterial natriuretic pepitde in patients with chronic heart failure. JACC 1989; 13:1534-9.
21. De Lemos JA, Morrow DA. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001;345:1014-21.
22. Fisher C, Berry C, Blue L, Morton JJ, McMurray J. N-tproBNP, but not the new putative cardiac hormone relaxin, predicts prognosis in patients with chronic heart failure. Heart 2003 Aug;89(8):879-81.
23. James SK, Lindhal B, Siegalbhan A. Nt proBNP and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease.GUSTO-IV sub study: Circulation 2003 July22;108(3):275-81.
24. Moser P, Stanek B, Pacher R. BNP predicts sudden death in patients with chronic heart failure. Circulation 2002; 105:2392-7.
25. Weber M, Hamm C.Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine.Heart 2006 Jun;92(6):843-9.
26. Nakamura M, Endo H. Value of plasma B-type natriuretic peptide measurement for heart disease screening in a Japanese population Heart. 2002;87(2):131-5.
27. Isabgel H., Jose L, Arneau MA,et el. Ventricular natriuretic peptides (BNP) in heart transplantation; BNP correlation with endomyocardial bioipsy, laboratory and heamodynamic measures. Laboratory Invest 2003 p.1-8.
28. Holtwick R. Pressure independent cardiac hypertrophy in mice with cardiomyocyte restricted inactivation of the atrial natriuretic peptide receptor Guanyl cyclase. J Clin. Invest 2003 ;111:1399-1407.
29. Buckley MG, Markandu ND. Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-dependent or dialysis independent chronic renal failure. Clin Investigation 1992;83:437-44.
30. Kohno M, Horio T, Yokokowa K, Murakawa K. Brain natriuretic peptide as a novel cardiac hormone in essential hypertension. Am J Med 1992;201:29-34.
31. Yandle TG, Richards AM, Gilbert A. Assay of brain natriuretic peptide in human plasma: Evidence for high molecular weight BNP as a major plasma component in heart failure. J Clin. Endocrinol Metab.1993;76:832-38.
32. Lang CC, Coutie W J, Khong TK, Choy AM. Dietary sodium loading increases plasma brain natriuretic peptide levels in man. J Hypertens 1991;9:779-82.
33. Matsumo A. Effects of exercise on plasma level of BNP in CHF with and without left ventricular dysfunction. Am Heart J 1995;129:139-45.
34. Ikeda T, Matsuda K, Itoh H. Plasma levels of brain natriuretic peptides and atrial natriuretic peptide elevate in proportion to left ventricular end systolic wall stress in patients with aortic stenosis. Am Heart J 1997;133:307-14.
35. Thurpaf DJ, Glembotski CC. Differential effects of protein kinase C, RAS and RAF-1 kinase on induction of the cardiac B-type natriuretic peptide gene through a critical promotor-proximal M-CAT element. J Biol. Chem 1997; 272:7464-72.
36. Hasegawa K, Fujiwara H, Doyama K, Miyamae M. Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy. Circulation 1993;88:372-80.
37. Morita E, Yasue H, Yoshimura M, Ogawa H. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 1993; 88: 82-91.
38. Buckley MG, Markandu ND. Brain and atrial natriuretic peptides: a dual peptide system of potential importance in sodium balance and blood pressure regulation in patients with essential hypertension J Hypertens. 1994;12:809-13.
39. Melanson SE, Lewandrowski EL.Laboratory testing for Btype natriuretic peptides (BNP and NT-proBNP): clinical usefulness, utilization, and impact on hospital operations. Am J Clin Pathol 2005 Dec;124 Suppl:S122-8.